Revvity, Inc. is set to announce its fourth-quarter 2025 results on February 2, expecting revenues of $767.2 million—up 5.2% from last year. However, the company anticipates a concerning 9.2% decline in earnings per share, projecting a figure of $1.55. Despite beating earnings estimates in the past four quarters with an average surprise of 4.16%, Revvity holds a Zacks Rank of #3, suggesting caution among analysts as market reactions may vary.
“Revvity, Inc. · is slated to report · fourth-quarter 2025 results · on Feb. 2, before market open”
“Revvity, Inc. · delivered an earnings surprise of · 3.51%”
“Revvity, Inc. · had earnings that beat estimates · in each of the trailing four quarters”
“Revvity, Inc. · delivered an average surprise of · 4.16%”
“Revvity, Inc. · is expected to have · a stable Life Sciences performance”
“Revvity, Inc. · anticipates its revenues for fourth-quarter 2025 · to be pegged at · $767.2 million”
“Revvity, Inc. · is expected to experience a deterioration of · 9.2% year over year · in earnings per share”
“Revvity, Inc. · carries a Zacks Rank · #3”
“Revvity (RVTY) · will report quarterly earnings of · $1.55 per share · true”
“Revvity (RVTY) · will report · revenues · $767.2 million”
“Revvity (RVTY) · will report revenues exhibiting an increase of · 5.2% compared to the year-ago quarter · true”
“shares of Revvity · have returned · +17.6% · true”